Literature DB >> 10465693

Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.

M Durand1, O Berton, S Aguerre, L Edno, I Combourieu, P Mormède, F Chaouloff.   

Abstract

In keeping with the anxiolytic property of selective serotonin reuptake inhibitors (SSRIs) in humans, we have examined in the spontaneously hypertensive rat (SHR) and the Wistar-Kyoto (WKY) rat, which display low and high anxiety, respectively, some psychoneuroendocrine effects of a repeated treatment with the SSRI fluoxetine (5 or 10 mg/kg daily, for 3 weeks). Two days after the last injection, plasma levels of fluoxetine were not detectable whereas those of its metabolite, norfluoxetine, were present to similar extents in both strains. By means of the elevated plus-maze test (29-30 h after the 13th administration of fluoxetine) and an open field test (48 h after the last injection of fluoxetine), it was observed that fluoxetine pretreatment did not yield anxiolysis; hence, some, but not all, behaviours were indicative of anxiety and hypolocomotion (as assessed through principal component analyses and acute diazepam studies). In both strains, the 10 mg/kg dose of fluoxetine decreased hypothalamus 5-HT and 5-HIAA levels, and reduced midbrain and/or hippocampus [3H]citalopram binding at 5-HT transporters, but did not affect [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding at hippocampal 5-HT1A receptors. However, the fluoxetine-elicited reduction in hippocampal 5-HT transporter binding was much more important in WKY than in SHR rats, this strain-dependent effect being associated in WKY rats with a reduction in cortical [3H]ketanserin binding at 5-HT2A receptors. Lastly, in WKY rats, repeated fluoxetine administration increased adrenal weights and the plasma corticosterone response to open field exposure, but did not affect the binding capacities of hippocampal mineralocorticoid and glucocorticoid receptors. These data show that key psychoneuroendocrine responses to repeated fluoxetine administration may be strain-dependent, and that repeated fluoxetine administration does not yield anxiolysis, as assessed by two standard tests of emotivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465693     DOI: 10.1016/s0028-3908(99)00009-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  27 in total

1.  Overexpression or knockdown of rat tryptophan hyroxylase-2 has opposing effects on anxiety behavior in an estrogen-dependent manner.

Authors:  R Hiroi; R A McDevitt; P A Morcos; M S Clark; J F Neumaier
Journal:  Neuroscience       Date:  2010-12-20       Impact factor: 3.590

2.  Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field.

Authors:  R Hiroi; J F Neumaier
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

3.  Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation.

Authors:  Emily V Ho; Summer L Thompson; William R Katzka; Mitra F Sharifi; James A Knowles; Stephanie C Dulawa
Journal:  Psychopharmacology (Berl)       Date:  2015-09-30       Impact factor: 4.530

4.  Intrahippocampal Effects of Nickel Injection on the Affective and Cognitive Response in Wistar Rat: Potential Role of Oxidative Stress.

Authors:  Mohamed Yassine El Brouzi; Mouloud Lamtai; Oussama Zghari; Sihame Ouakki; Ibrahim Azizoun; Aboubaker El Hessni; Abdelhalem Mesfioui; Ali Ouichou
Journal:  Biol Trace Elem Res       Date:  2020-11-23       Impact factor: 3.738

5.  Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress.

Authors:  Michael S Clark; Timothy J Sexton; Molly McClain; Daniel Root; Ruth Kohen; John F Neumaier
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

6.  Exposure to an open-field arena increases c-Fos expression in a subpopulation of neurons in the dorsal raphe nucleus, including neurons projecting to the basolateral amygdaloid complex.

Authors:  M W Hale; A Hay-Schmidt; J D Mikkelsen; B Poulsen; J A Bouwknecht; A K Evans; C E Stamper; A Shekhar; C A Lowry
Journal:  Neuroscience       Date:  2008-10-04       Impact factor: 3.590

7.  Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity.

Authors:  Jonathan G McEuen; Katharine A Semsar; Maria A Lim; Tracy L Bale
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

8.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

9.  Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.

Authors:  Elizabeth I Flandreau; Chase H Bourke; Kerry J Ressler; Wylie W Vale; Charles B Nemeroff; Michael J Owens
Journal:  Psychoneuroendocrinology       Date:  2012-12-23       Impact factor: 4.905

10.  Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.

Authors:  Caterina M Hernandez; Helga Høifødt; Alvin V Terry
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.